Min Zheng

Title: The Innovative Contributions of Min Zheng in Hematology

Introduction

Min Zheng, an accomplished inventor based in Pembroke Pines, Florida, holds a remarkable portfolio of five patents. His work primarily focuses on advancements in hematology, reflecting his dedication to enhancing blood sample analysis and measurement accuracy.

Latest Patents

Among his latest innovations, Zheng has developed a significant method for correcting particle interference in hemoglobin measurement. This method involves mixing a blood sample with a lytic reagent, measuring absorbance at a specific wavelength, and removing contributions from cellular particles to provide a corrected hemoglobin concentration. Another noteworthy patent addresses the prevention of white blood cell interference in the measurement of mean cell volume (MCV), red blood cell concentration (RBC), and hematocrit (Hct) of blood samples. By defining specific regions in red blood cell distribution histograms and adjusting for white blood cell concentration, the accuracy of these critical measurements is greatly enhanced.

Career Highlights

Min Zheng’s career has been marked by impressive professional experiences, particularly at Beckman Coulter, Inc. and Coulter International Corporation. His roles in these leading companies have allowed him to apply his innovative ideas in practical settings, contributing to significant advancements in medical diagnostics.

Collaborations

Throughout his inventive journey, Zheng has collaborated with notable peers in his field, including Shuliang Zhang and Jing Li. These collaborations underscore the importance of teamwork in achieving groundbreaking results in scientific research and innovation.

Conclusion

Min Zheng's contributions to the field of hematology through his patents exemplify the crucial intersection of innovation and healthcare. His work not only improves measurement techniques but also enhances the reliability of blood tests, ultimately benefiting medical diagnostics and patient care.